Serial Number
97804225
Owner
PAPA HEALTH. INCAttorney
Joe McKinney MuncyFirst Use Date
Dec 15, 2022
Filing Date
Feb 21, 2023
CANNAPRESSO Trademark
Serial Number: 97804225 • Registration: 8320326
Trademark Classes
Owner Contact Info
202 N. CALIFORNIA AVE STE A
CITY OF INDUSTRY,, CA 91744
Entity Type: 03
Legal Representation
Correspondence Address
Joe McKinney Muncy Muncy, Geissler, Olds & Lowe PLLC
125 S. Royal St.
Alexandria, VA 22314
United States
Trademark Details
Filing Date
February 21, 2023
Registration Date
June 30, 2026
First Use Anywhere
December 15, 2022
First Use in Commerce
December 15, 2022
Published for Opposition
May 12, 2026
Goods & Services
Cartomizers, namely, combination electronic cigarette refill cartridges sold empty and atomizers, sold as a component of electronic cigarettes; Cartridges sold filled with chemical flavorings in liquid form, other than essential oils, for electronic cigarettes; Cases for electronic cigarettes and electronic cigarette accessories; Chemical flavorings in liquid form, other than essential oils, used to refill electronic cigarette cartridges; Devices for heating tobacco for the purpose of inhalation; Electronic cigarette atomizers sold empty; Electronic cigarette cases; Electronic cigarette liquid (e-liquid) comprised of flavorings in liquid form, other than essential oils, used to refill electronic cigarette cartridges; Electronic cigarette liquid (e-liquid) comprised of propylene glycol and not including essential oils; Electronic cigarette liquid (e-liquid) comprised of vegetable glycerin and not including essential oils; Electronic cigarettes sold empty; Electronic cigarettes and oral vaporizers for smokers sold empty; Electronic cigarettes for use as an alternative to traditional cigarettes sold empty; Flavourings, other than essential oils, for use in electronic cigarettes; Liquid nicotine solutions for use in electronic cigarette; Smokers' mouthpieces for electronic cigarettes, cigars, cigarettes; Tobacco and tobacco substitutes; Tobacco substitutes not for medical purposes; any CBD in the goods being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; all of the foregoing cannabis-related goods containing cannabis ingredients solely derived from hemp with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis with the resulting goods containing a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis